Compounded medications from licensed 503A pharmacies contain the same active pharmaceutical ingredients as brand names but cost 70-85% less because they avoid manufacturer overhead
Semaglutide is generally recommended for our adult patients with a BMI of 30 or more (or a BMI of 27 with a weight-related health condition such as high blood pressure or type 2 diabetes) who are seeking assistance with weight loss
According to the **TRIUMPH-1 Phase 3 trial results published by Eli Lilly in May 2026**, Retatrutide at the 12mg maintenance dose produced an average of 28.3% body weight reduction over 80 weeks
Early studies suggest that semaglutide treatment leads to beneficial changes in gut bacteria populations, including increases in anti-inflammatory bacterial strains
Thyroid function monitoring should be intensified during the initial phases of GLP-1 treatment and during periods of significant weight loss
In some cases, the doctor may order additional tests, such as blood tests or an electromyography (EMG), to measure the electrical activity of the muscles around the eye